Skip to main content
RGNX $7.16 -0.28%
RGNX logo
RGNX · REGENXBIO Inc.
Track RGNX — free
$7.16 -0.02 (-0.28%) At close · Nov 20 Play latest call Q3 2026 earnings call transcript
Market Cap
$473.44M
Shares
66.12M
Volume · Nov 20 1.06M Avg daily vol (3M) 1.38M
All webcasts

Earnings call · FY2025 Q2

REGENXBIO Inc. (RGNX) Q2 2025 Earnings Call

Concluded Aug 7, 2025
Aug 7, 2025
Period
FY2025 Q2
Runtime
—
Sources
2 artifacts
Revenue $21.36M -4.2% YoY
Diluted EPS -$1.38
Net income -$70.87M
Open full screen 8-K 10-Q

Executive readout · one minute

Webcast research workspace

Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Research materials

Open the source you need; every reader stays inside this workspace.

Quarter detail

How the reported period landed and where the business moved.

Revenue · products & services

Zolgensma Royalties$18.42M -15.3% YoY
Nippon Shinyaku Services$2.72M
Other Service Revenue$174,000 -61.2% YoY
Full-screen source Call document